Key Record Dates
| ClinicalTrials.gov Identifier: | NCT03602859 |
|---|---|
| Brief Title: | A Phase 3 Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer (FIRST) |
| First Submitted : | June 28, 2018 |
| First Submitted that Met QC Criteria : | July 18, 2018 |
| First Posted : | July 27, 2018 |
| Last Update Submitted that Met QC Criteria : | January 27, 2021 |
| Last Update Posted : | January 28, 2021 |